Search research articles
Contact Us
Filters
Showing results (71-80 of 88) with videos related to
Page
of 9
Sort By:
Human Molecular Genetics
|
October 22, 2005
Polymorphism discovery in 51 chemotherapy pathway genes
Robert R Freimuth, Ming Xiao, Sharon Marsh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 6, 2007
A phase II study of irinotecan and carboplatin in advanced non-small cell lung cancer with pharmacogenomic analysis: final report
Giancarlo A Pillot, William L Read, Kristin L Hennenfent, et al.
The Journal of Rheumatology
|
April 3, 2008
Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis
Prabha Ranganathan, Robert Culverhouse, Sharon Marsh, et al.
Pharmacogenomics
|
October 16, 2008
Génome Québec & Montreal Heart Institute Pharmacogenomics Centre: a translational pharmacogenomics platform--from R&D to the clinic
Michael S Phillips, Abdelmadjid K Hihi, Tibor van Rooij, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2008
Irinotecan pharmacogenetics: influence of pharmacodynamic genes
Janelle M Hoskins, Eugenio Marcuello, Albert Altes, et al.
Cancer Research
|
October 6, 2005
CpG island methylation of DNA damage response genes in advanced ovarian cancer
Jens M Teodoridis, Jacqueline Hall, Sharon Marsh, et al.
European Journal of Clinical Pharmacology
|
April 4, 2007
Identification of NR1I2 genetic variation using resequencing
Cristi R King, Ming Xiao, Jinsheng Yu, et al.
Pharmacogenetics and Genomics
|
June 16, 2009
Platinum pathway
Sharon Marsh, Howard McLeod, Eileen Dolan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 22, 2005
Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxel
Anja Henningsson, Sharon Marsh, Walter J Loos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2006
Hoosier Oncology Group randomized phase II study of docetaxel, vinorelbine, and estramustine in combination in hormone-refractory prostate cancer with pharmacogenetic survival analysis
Noah M Hahn, Sharon Marsh, William Fisher, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 88) with videos related to
Sort By:
Page
of 9
Human Molecular Genetics
|
October 22, 2005
Polymorphism discovery in 51 chemotherapy pathway genes
Robert R Freimuth, Ming Xiao, Sharon Marsh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 6, 2007
A phase II study of irinotecan and carboplatin in advanced non-small cell lung cancer with pharmacogenomic analysis: final report
Giancarlo A Pillot, William L Read, Kristin L Hennenfent, et al.
The Journal of Rheumatology
|
April 3, 2008
Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis
Prabha Ranganathan, Robert Culverhouse, Sharon Marsh, et al.
Pharmacogenomics
|
October 16, 2008
Génome Québec & Montreal Heart Institute Pharmacogenomics Centre: a translational pharmacogenomics platform--from R&D to the clinic
Michael S Phillips, Abdelmadjid K Hihi, Tibor van Rooij, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2008
Irinotecan pharmacogenetics: influence of pharmacodynamic genes
Janelle M Hoskins, Eugenio Marcuello, Albert Altes, et al.
Cancer Research
|
October 6, 2005
CpG island methylation of DNA damage response genes in advanced ovarian cancer
Jens M Teodoridis, Jacqueline Hall, Sharon Marsh, et al.
European Journal of Clinical Pharmacology
|
April 4, 2007
Identification of NR1I2 genetic variation using resequencing
Cristi R King, Ming Xiao, Jinsheng Yu, et al.
Pharmacogenetics and Genomics
|
June 16, 2009
Platinum pathway
Sharon Marsh, Howard McLeod, Eileen Dolan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 22, 2005
Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxel
Anja Henningsson, Sharon Marsh, Walter J Loos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2006
Hoosier Oncology Group randomized phase II study of docetaxel, vinorelbine, and estramustine in combination in hormone-refractory prostate cancer with pharmacogenetic survival analysis
Noah M Hahn, Sharon Marsh, William Fisher, et al.
Page
of 9